Quienes hayan received the dosages of the Pfizer vacancies at BioNTech podrían requires one more injection (or varias). Albert Bourla, Pfizer CEO, revealed that the pharmaceuticals analyze the possibility of applying a third dose of its vaccine against COVID-19, which is not certain about the time of effectiveness.
“A probable hypothesis is that a third dose is needed, between the 6th and the 12th month, and it is from here that you will need to wake up every year, but everything you need to confirm”, Dijo the CEO of Pfizer according to CNBC.
“For another lad, the variants (of the virus) play a fundamental paper”, agregó Bourla. “It is extremely important to maximize the number of vulnerable people to the virus”.
Recently, the doctor David Kessler, Chief Scientist of the Response Team of the COVID-19 Team of Administration Joe Biden, on the possible need for a third dose of vaccine reflux to protect coronavirus circulating variants.
“At the moment we do not know everything”, Kessler admits during a hearing before the state legislators. “We are studying the duration of the response of the antiquities”, dijo.
In February passed, the alliance Pfizer-BioNTech announcement that they are conducting clinical trials to analyze the effects of a third dose of their vaccine variant.
La Pfizer and BioNTec vacancies to be a seministra en dos dosis to increase its maximum efficiency by 95%. This inoculator uses ARN technology to produce an immune response in the organism.
Without embarrassment, it has been known for some time during the protection of this and the rest of the vacancies against COVID-19, as a result of the study of such pharmaceuticals as organisms dedicated to health.